Incyte

Incyte Corporation, founded in 1991, is an established entity in the pharmaceuticals sector with its headquarters based in Wilmington, Delaware, USA. The company has carved out a strong presence in the field of biopharmaceuticals with a keen focus on the discovery, development, and commercialization of its own therapeutic products. Specializing in oncology and inflammation & autoimmunity, Incyte has made significant strides in addressing complex diseases. A flagship brand, Jakafi (ruxolitinib), exemplifies Incyte's commitment to innovation, offering treatments for a range of conditions including myelofibrosis, polycythemia vera, and graft-versus-host disease. With a wide-reaching influence, Incyte markets its products and services across the globe, with the United States and Europe standing as major markets. Furthermore, the company's international footprint continues to grow through strategic partnerships and the establishment of subsidiaries, ensuring that its therapeutic solutions are accessible in numerous countries worldwide. (Powered by AI)